Vitamin D and cardiovascular disease

被引：65

作者：

Jacqueline S. Danik

JoAnn E. Manson

机构：

[1] Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215

来源：

Current Treatment Options in Cardiovascular Medicine | 2012年 / 14卷 / 4期

关键词：

Cardiovascular disease; Diabetes; Diet; Hypertension; Omega 3 fatty acids; Prevention; Vitamin D;

D O I：

10.1007/s11936-012-0183-8

中图分类号：

学科分类号：

摘要：

Vitamin D has received widespread attention for its potential role in preventing cardiovascular disease (CVD) and type 2 diabetes mellitus. Several epidemiological studies have suggested that individuals with low blood levels of vitamin D have increased risks of heart disease, stroke, hypertension, and diabetes. Yet, the revised 2011 Institute of Medicine report for intake of calcium and vitamin D, which was guided by skeletal health alone, concluded that the evidence that vitamin D prevents CVD, diabetes, or other cardiometabolic outcomes was inconsistent and inconclusive and did not meet criteria for establishing a cause and effect relationship [1, 2]. This finding was consistent with an earlier systematic review conducted by the Agency for Healthcare Research and Quality (AHRQ) in 2009 [3]. Ongoing clinical trials seek to address the effects of vitamin D supplementation on CVD and other nonskeletal outcomes. © Springer Science+Business Media, LLC 2012.

引用

页码：414 / 424

页数：10

共 101 条

[1]

Ross A.C., Manson J.E., Abrams S.A., Et al., The 2011 report on dietary reference intakes for calcium and vitamin d from the institute of medicine: What clinicians need to know, J Clin Endocrinol Metab, 96, 1, pp. 53-58, (2011)

[2]

Chung M., Balk E.M., Brendel M., Et al., Vitamin D And Calcium: A Systematic Review Of Health Outcomes, (2009)

[3]

Norman A.W., From vitamin D to hormone D: Fundamentals of the vitaminDendocrine systemessential for good health, Am J Clin Nutr, 88, 2, (2008)

[4]

Holick M.F., Vitamin D deficiency, N Engl J Med, 357, 3, pp. 266-281, (2007)

[5]

Chun R.F., Adams J.S., Hewison M., Back to the future: A new look at 'old' vitamin D, J Endocrinol, 198, 2, pp. 261-269, (2008)

[6]

Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., Modlin R.L., Adams J.S., Extra-renal 25-hydroxyvitamin D<sub>3</sub>-1α-hydroxylase in human health and disease, Journal of Steroid Biochemistry and Molecular Biology, 103, 3-5, pp. 316-321, (2007)

[7]

Adams J.S., Hewison M., Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity, Nature Clinical Practice Endocrinology and Metabolism, 4, 2, pp. 80-90, (2008)

[8]

Zhou S., LeBoff M.S., Glowacki J., Vitamin D metabolism and action in human bone marrow stromal cells, Endocrinology, 151, 1, pp. 14-22, (2010)

[9]

Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., Petruschke R.A., Chen E., De Papp A.E., Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy, Journal of Clinical Endocrinology and Metabolism, 90, 6, pp. 3215-3224, (2005)

[10]

Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R., Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III, Bone, 30, 5, pp. 771-777, (2002)

← 1 2 3 4 5 6 7 8 9 10 →